Maryvonne Hiance Chairman of France Biotech
Atlanpole Biotherapies is pleased to announce the election of one of its iconic entrepreneur : Maryvonne Hiance, who is... View Article
Research Summer School
The University of Angers is very pleased to announce the Summer Schools Angers 2016. From 27th June to 8th July,... View Article
CESTI IHU: INNOVATION TOWARDS IMMUNE SYSTEM MODULATION
CESTI IHU: towards an innovative therapy aiming at modulating the immune system The research program led by Prof. Karin... View Article
XENOTHERA closes a new capital increase above 2 million euros
XENOTHERA, a young biotech who develops an innovative immunosuppressant, has closed on June 2nd, 2016, a second fundraising for more... View Article
First sales of Flu Vaccines Produced on Valneva’s EB66® Cell-Line
First sales of Flu Vaccines Produced on Valneva’s EB66® Cell-Line Valneva to begin receiving royalties for an EB66®-based human vaccine... View Article
InFlectis BioScience raises €6 million
InFlectis BioScience raises €6 million in a Series A round to perform clinical trial in humans. Nantes, France – June... View Article
OSE Pharma merge with Effimune to create OSE Immunotherapeutics
OSE Pharma and Effimune shareholders approve merger to create OSE Immunotherapeutics Paris, Nantes, May 31, 2016 – OSE Pharma SA... View Article
Effimune, launch of an hepatocellular carcinoma study
OSE Pharma and Effimune announce the launch of a non-interventional study in hepatocellular carcinoma under a private-public collaborative program. Paris,... View Article
BIND Therapeutics Announces Collaboration with Affilogic
BIND Therapeutics Announces Collaboration with Affilogic to Provide BIND with Access to Targeting Ligands that are Key Modulators of Anti-tumor... View Article
Ipi Santé : new member
IPISANTE is developing a customized web collaborative tool, and is performing, for healthcare and wellness professionals, digital solutions which are... View Article